Deciphering the significance of CD56 expression in pediatric acute myeloid leukemia: a report from the Children's oncology group
Background In patients with acute myeloid leukemia (AML), CD56 expression has been
associated with adverse clinical outcome. We reported on a phenotype associated with very …
associated with adverse clinical outcome. We reported on a phenotype associated with very …
Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in China
KT Leung, J Cai, Y Liu, KYY Chan, J Shao, H Yang… - Leukemia, 2024 - nature.com
The outcomes of children with acute lymphoblastic leukemia (ALL) have been incrementally
improved with risk-directed chemotherapy but therapy responses remain heterogeneous …
improved with risk-directed chemotherapy but therapy responses remain heterogeneous …
[HTML][HTML] Correlation of CD123 expression level with disease characteristics and outcomes in pediatric acute myeloid leukemia: a report from the Children's Oncology …
AJ Lamble, LE Brodersen, TA Alonzo, J Wang… - Blood, 2019 - Elsevier
Introduction: Despite maximally intensified chemotherapy, cure rates remain suboptimal for
children and young adults with acute myeloid leukemia (AML). As CD123 (IL3RA) is …
children and young adults with acute myeloid leukemia (AML). As CD123 (IL3RA) is …
CD123 expression is associated with high-risk disease characteristics in childhood acute myeloid leukemia: a report from the Children's Oncology Group
AJ Lamble, L Eidenschink Brodersen… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Increased CD123 surface expression has been associated with high-risk
disease characteristics in adult acute myeloid leukemia (AML), but has not been well …
disease characteristics in adult acute myeloid leukemia (AML), but has not been well …
Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non‐M3 Acute Myeloid Leukemia
Y Sun, J Wan, Q Song, C Luo, X Li… - BioMed Research …, 2021 - Wiley Online Library
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia
C Chen, CL Chio, H Zeng, Y Li - Hematology, 2021 - Taylor & Francis
ABSTRACT Objectives Previous study (Br. J. Haematol. 2017; 176: 498) reported that CD56
positive is associated with poor prognosis of patients with intermediate-risk acute myeloid …
positive is associated with poor prognosis of patients with intermediate-risk acute myeloid …
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM‐phenotype acute myeloid leukemia and study of its clinicopathological characteristics
D Panda, G Chatterjee, R Sardana… - Cytometry Part B …, 2021 - Wiley Online Library
Abstract Introduction In 2016, Children Oncology Group (COG) described a new high‐risk
subtype of acute myeloid leukemia (AML) with a distinct immunophenotypic‐signature, RAM …
subtype of acute myeloid leukemia (AML) with a distinct immunophenotypic‐signature, RAM …
Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens
Background Aberrant expression of myeloid antigens (MyAgs) on acute lymphoblastic
leukemia (ALL) cells is a well-documented phenomenon, although its regulating …
leukemia (ALL) cells is a well-documented phenomenon, although its regulating …
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment
B Buldini, E Varotto, M Maurer-Granofszky, G Gaipa… - Blood, 2024 - ashpublications.org
In the effort to improve immunophenotyping and minimal residual disease (MRD)
assessment in acute lymphoblastic leukemia (ALL), the international Berlin-Frankfurt …
assessment in acute lymphoblastic leukemia (ALL), the international Berlin-Frankfurt …
Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients
S Aref, E Azmy, K El-Bakry, L Ibrahim… - Pediatric Hematology …, 2017 - Taylor & Francis
This study aimed to determine the prognostic impact of CD200 and CD56 expression in
pediatric B cell acute lymphoblastic leukemia (B-ALL) patients, both of which have been …
pediatric B cell acute lymphoblastic leukemia (B-ALL) patients, both of which have been …